Business Description
LeonaBio Inc., formerly Athira Pharma, is a clinical-stage company based in Bothell, Washington, working to develop treatments that protect and restore brain cell health. Its two lead drug candidates, ATH-1105 and ATH-1020, are both in early-stage human trials targeting conditions such as ALS and other diseases that cause the brain and nervous system to deteriorate over time. The company also has additional treatments in earlier stages of research and development.
